Here's a question most GLP-1 comparison sites never ask: does your provider actually look at your bloodwork before prescribing you a medication that changes how your body processes sugar, stores fat, and moves food through your digestive system?
The answer, for a surprising number of telehealth providers, is no. They'll ask you to self-report your medical history on a questionnaire, but they won't require or even recommend that anyone verify those self-reports with actual lab data. This isn't illegal — telehealth prescribing standards allow clinical judgment based on patient-reported history — but it represents a gap between what's legally permissible and what's clinically ideal.
GLP-1 medications can cause dehydration through nausea, reduced fluid intake, and GI side effects. For patients with pre-existing kidney issues — including kidney disease they may not know about — this dehydration risk is amplified. A basic metabolic panel showing creatinine and eGFR establishes your kidney function baseline before treatment and flags patients who need closer monitoring.
Many patients starting GLP-1 treatment for weight loss have undiagnosed pre-diabetes or type 2 diabetes. An A1C test before treatment serves two purposes: it identifies patients who should be on GLP-1 medications for diabetes management (which affects insurance coverage and clinical protocols), and it provides a baseline for tracking metabolic improvement during treatment.
GLP-1 medications have demonstrated cardiovascular benefits — improved cholesterol profiles, reduced triglycerides, and lower cardiovascular event risk. A pre-treatment lipid panel establishes the baseline against which these improvements can be measured. It also identifies patients with severe dyslipidemia who may need additional cardiovascular intervention alongside GLP-1 treatment.
GLP-1 medications carry a boxed warning regarding medullary thyroid carcinoma (MTC) risk, based on animal studies. While the human risk appears very low, screening for thyroid abnormalities before treatment is prudent — and it's part of the contraindication screening that questionnaires alone can miss.
Liver enzymes (ALT, AST) in a metabolic panel flag liver conditions that could affect how your body processes medications. GLP-1s are showing promise for fatty liver disease in clinical research, but patients with active liver conditions need appropriate monitoring.
Some providers require baseline bloodwork before prescribing and won't issue a prescription until results are reviewed. This approach mirrors traditional medical practice and provides the strongest safety foundation. The downside: it adds time and potentially cost to the onboarding process.
Many mid-tier providers recommend baseline labs but don't mandate them. They'll suggest specific tests, may provide lab order forms, and will review results if you provide them — but they won't block prescribing if you decline. This approach respects patient autonomy while still encouraging best practices.
Budget providers typically leave lab work entirely to the patient. They'll prescribe based on your questionnaire responses and assume you'll get labs through your primary care physician if needed. This works well for patients who have an active PCP relationship; it creates a gap for patients who use the telehealth provider as their primary (or only) healthcare relationship.
Embody's provider-led clinical model includes lab recommendations as part of the treatment management process. Your dedicated prescribing provider can order labs, review results, and adjust your treatment plan based on objective data — not just self-reported symptoms. This level of lab integration is what you'd expect from an in-person medical practice, delivered through a telehealth platform.
Pricing: $149 first month, $299/mo ongoing
Medications: Compounded injectable semaglutide
Injectable semaglutide only — custom treatment plans with ongoing clinical support.
Visit Embody → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
Found's comprehensive intake process includes health screening that goes beyond a basic questionnaire. The coaching and clinical components create multiple touchpoints where lab abnormalities would be identified and addressed. For patients who want a provider that treats GLP-1 prescribing as part of broader health management, Found's model encourages the most complete picture of your health.
Pricing: From $129/mo (medication extra)
Medications: Compounded & brand-name GLP-1 options
Personalized weight care with coaching, nutrition guidance, and GLP-1 access.
Visit Found Health → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
Sesame Care's live consultation model means you'll have a real-time conversation with a licensed provider who can discuss lab needs, order tests, and review results as part of the prescribing process. Since Sesame prescribes brand-name medications, the clinical pathway more closely mirrors traditional medical practice, where labs are a standard part of prescribing.
Pricing: From $49/visit + medication cost
Medications: FDA-approved brand-name GLP-1 medications
Affordable telehealth consultations for FDA-approved brand-name GLP-1 prescriptions. Sesame connects you with licensed providers who can prescribe brand-name medications like Wegovy and Zepbound.
Visit Sesame Care → Paid linkIvim's insurance concierge service can help patients access lab work through their insurance benefits, reducing out-of-pocket lab costs. For patients whose insurance covers routine bloodwork, Ivim's guidance on getting labs covered can eliminate the cost barrier that leads many patients to skip labs entirely.
Pricing: From $199/mo
Medications: Compounded semaglutide & tirzepatide
Insurance concierge support with affordable compounded GLP-1 options.
Visit Ivim Health → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
If your GLP-1 provider doesn't facilitate lab work, you can still get baseline bloodwork through several channels:
Regardless of how you get labs done, share the results with your GLP-1 prescribing provider. Even providers that don't require labs will use them if you provide them — and having objective data in your medical record improves the quality of care you receive.
| Provider | Starting Price | Medications | |
|---|---|---|---|
| Embody | $149 first month, $299/mo ongoing | Compounded injectable semaglutide | Visit → Paid link |
| Found Health | From $129/mo (medication extra) | Compounded & brand-name GLP-1 options | Visit → Paid link |
| Sesame Care Brand-name only | From $49/visit + medication cost | FDA-approved brand-name GLP-1 medications | Visit → Paid link |
| Ivim Health | From $199/mo | Compounded semaglutide & tirzepatide | Visit → Paid link |
| Wellorithm | Check provider | Compounded GLP-1 medications | Visit → Paid link |
| Oak Weight Loss | Check provider | Compounded semaglutide & tirzepatide | Visit → Paid link |
| Care Bare Rx | From $199/mo | Compounded semaglutide | Visit → Paid link |
| GobyMeds | Semaglutide $99/mo, Tirzepatide $133/mo | Compounded semaglutide & tirzepatide, plus NAD+ and Sermorelin | Visit → Paid link |
Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. All provider links are paid affiliate links.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Compare GLP-1 is an independent comparison site not affiliated with any pharmaceutical manufacturer, telehealth provider, or government agency.
Affiliate Disclosure: We may earn a commission when you sign up through links on this page, at no additional cost to you. This helps support our independent research. All provider links marked "Paid link" are affiliate links.